Dana-Farber Cancer Institute shared on LinkedIn:
“In collaboration with Boston Children’s Hospital and Broad Clinical Labs, we’re excited to announce the launch of BrightSeq – a new precision genomics initiative set to advance pediatric cancer diagnostics and research.
“This collaborative model will empower us to address urgent needs in pediatric cancer research while also returning critical results to patients and families,” noted Kimberly Stegmaier, Chair of the Department of Pediatric Oncology.
More posts featuring Dana-Farber Cancer Institute.